Regenerative Medicine

DiscGenics Announces US FDA Approval to Proceed with Phase III Clinical Evaluation of Allogeneic, Injectable Disc Progenitor Cell Therapy for Symptomatic Lumbar Degenerative Disc Disease

"DiscGenics allogeneic disc progenitor cell therapy"

2 min read

DiscGenics Announces US FDA Approval to Proceed with Phase III Clinical Evaluation of Allogeneic, Injectable Disc Progenitor Cell Therapy for Symptomatic Lumbar Degenerative Disc Disease

DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company developing allogeneic, cell-based, regenerative therapies for musculoskeletal degeneration,...

TETROUS ANNOUNCES FIRST SURGICAL PROCEDURES USING ENFIX TAC™ DEMINERALIZED BONE FIBER IMPLANTS TO ENHANCE ENTHESIS HEALING IN ROTATOR CUFF REPAIR

2 min read

TETROUS ANNOUNCES FIRST SURGICAL PROCEDURES USING ENFIX TAC™ DEMINERALIZED BONE FIBER IMPLANTS TO ENHANCE ENTHESIS HEALING IN ROTATOR CUFF REPAIR

TETROUS, INC., a leading regenerative medicine company today announced that it has completed the first surgical cases...

Xylyx Bio announces exclusive license agreement with Vanderbilt University for donor organ rehabilitation asset

Xylyx Bio and Vanderbilt University Agreement

1 min read

Xylyx Bio announces exclusive license agreement with Vanderbilt University for donor organ rehabilitation asset

Xylyx Bio, a regenerative medicine company developing innovative solutions for tissue and organ repair, today announced entry...

X-Therma Announces XT-Thrive® Drug Master File (DMF) Accepted by U.S. Food and Drug Administration (FDA)

Cryopreservation Technology Illustration

2 min read

X-Therma Announces XT-Thrive® Drug Master File (DMF) Accepted by U.S. Food and Drug Administration (FDA)

X-Therma Inc., a biotechnology company developing a breakthrough platform for regenerative medicine and organ preservation, announces that...

LyGenesis Announces First Patient Dosed in its Phase 2a Clinical Trial of a First-in-Class Regenerative Cell Therapy for Patients with End-Stage Liver Disease

Allogenic Regenerative Cell Therapy for End-Stage Liver Disease

2 min read

LyGenesis Announces First Patient Dosed in its Phase 2a Clinical Trial of a First-in-Class Regenerative Cell Therapy for Patients with End-Stage Liver Disease

LyGenesis, a clinical-stage biotechnology company developing cell therapies for large unmet medical needs, announced today that the...

Ajinomoto Co., Inc. Enhances StemFit iPS Cell Expansion Medium

3 min read

Ajinomoto Co., Inc. Enhances StemFit iPS Cell Expansion Medium

Today, Ajinomoto Co., Inc. (“Ajinomoto Co.”) (TSE: 2802) launched a new version of its StemFit™ iPSC expansion medium....

Human Acellular Vessel™ (HAV™) Biologics License Application Granted Priority Review by U.S. FDA for the Treatment of Vascular Trauma

3 min read

Human Acellular Vessel™ (HAV™) Biologics License Application Granted Priority Review by U.S. FDA for the Treatment of Vascular Trauma

Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial...

REGENATIVE LABS, TOGETHER WITH THE PAIN AND SLEEP THERAPY CENTER, PUBLISHES CASE STUDY DEMONSTRATING NEW CARE ADVANCEMENTS USING WHARTON’S JELLY ALLOGRAFTS IN TEMPOROMANDIBULAR JOINT DEFECTS

4 min read

REGENATIVE LABS, TOGETHER WITH THE PAIN AND SLEEP THERAPY CENTER, PUBLISHES CASE STUDY DEMONSTRATING NEW CARE ADVANCEMENTS USING WHARTON’S JELLY ALLOGRAFTS IN TEMPOROMANDIBULAR JOINT DEFECTS

Regenative Labs (Regenative), a leading HCT/P manufacturer, announces the publication of a case study demonstrating new care...

Regenerative Medicine

DiscGenics Announces US FDA Approval to Proceed with Phase III Clinical Evaluation of Allogeneic, Injectable Disc Progenitor Cell Therapy for Symptomatic Lumbar Degenerative Disc Disease

TETROUS ANNOUNCES FIRST SURGICAL PROCEDURES USING ENFIX TAC™ DEMINERALIZED BONE FIBER IMPLANTS TO ENHANCE ENTHESIS HEALING IN ROTATOR CUFF REPAIR

Xylyx Bio announces exclusive license agreement with Vanderbilt University for donor organ rehabilitation asset

X-Therma Announces XT-Thrive® Drug Master File (DMF) Accepted by U.S. Food and Drug Administration (FDA)

LyGenesis Announces First Patient Dosed in its Phase 2a Clinical Trial of a First-in-Class Regenerative Cell Therapy for Patients with End-Stage Liver Disease

Ajinomoto Co., Inc. Enhances StemFit iPS Cell Expansion Medium

Human Acellular Vessel™ (HAV™) Biologics License Application Granted Priority Review by U.S. FDA for the Treatment of Vascular Trauma

REGENATIVE LABS, TOGETHER WITH THE PAIN AND SLEEP THERAPY CENTER, PUBLISHES CASE STUDY DEMONSTRATING NEW CARE ADVANCEMENTS USING WHARTON’S JELLY ALLOGRAFTS IN TEMPOROMANDIBULAR JOINT DEFECTS

You may have missed

Lupin’s Humrahi Expands to Heart Health

Boston Scientific Launches AVVIGO™+ Multi-Modality Guidance System in India

KW Delhi-6 Mall Joined Hands with Yashoda Healthcare to Spread Awareness on Breast Cancer

India’s reputation as the “Pharmacy to the World” is Potentially Under Threat Substandard Imports of IPA add to the Quality Burden